Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE47451
SERIAL NO

15783240

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI PHARM CO LTDGYEONGGI DO SOUTH KOREA GYEONGGI-DO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahn, Young Gil Seongnam-si, KR 29 97
Bae, In Hwan Hwaseong-si, KR 23 35
Byun, Eun Young Yongin-si, KR 5 32
Han, Sang Mi Seoul, KR 7 41
Jun, Seung Ah Hwaseong-si, KR 5 26
Kim, Ho Seok Hwaseong-si, KR 13 73
Kwak, Eun Joo Hwaseong-si, KR 10 83
Son, Jung Beom Hwaseong-si, KR 26 121
Song, Ji Young Seoul, KR 23 56
Suh, Kwee Hyun Suwon-si, KR 43 97

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 25, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00